Administration of a C5aR1A significantly suppressed AKT phosphorylation, restored PTEN expression, reduced proteinuria, and alleviated renal tissue damage in LN mouse models, suggesting the therapeutic potential of targeting the C5a/C5aR1‐PTEN axis. Here, AKT1 is linked to lobular neoplasia.